149 related articles for article (PubMed ID: 9050950)
1. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
[TBL] [Abstract][Full Text] [Related]
2. Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancer.
Geisler J; Haarstad H; Gundersen S; Raabe N; Kvinnsland S; Lønning PE
J Endocrinol; 1995 Aug; 146(2):359-63. PubMed ID: 7561649
[TBL] [Abstract][Full Text] [Related]
3. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
Siegberg R; Nilsson CG; Stenman UH; Widholm O
Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
[TBL] [Abstract][Full Text] [Related]
5. Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients.
Lønning PE; Johannessen DC; Lien EA; Ekse D; Fotsis T; Adlercreutz H
J Steroid Biochem Mol Biol; 1995 May; 52(5):491-6. PubMed ID: 7748814
[TBL] [Abstract][Full Text] [Related]
6. Effect of anastrozole on hormone levels in postmenopausal women with early breast cancer.
Kyvernitakis I; Albert US; Kalder M; Winarno AS; Hars O; Hadji P
Climacteric; 2015 Feb; 18(1):63-8. PubMed ID: 24884402
[TBL] [Abstract][Full Text] [Related]
7. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
8. Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients.
Geisler J; Ekse D; Hösch S; Lønning PE
J Steroid Biochem Mol Biol; 1995 Nov; 55(2):193-5. PubMed ID: 7495698
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
Ellmén J; Hakulinen P; Partanen A; Hayes DF
Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
[TBL] [Abstract][Full Text] [Related]
10. Hormonal effects of toremifene in breast cancer patients.
Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
[TBL] [Abstract][Full Text] [Related]
11. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer.
Számel I; Vincze B; Hindy I; Hermann I; Borvendég J; Eckhardt S
Oncology; 1986; 43(1):7-11. PubMed ID: 3079899
[TBL] [Abstract][Full Text] [Related]
12. Association between alcohol intake and serum sex hormones and peptides differs by tamoxifen use in breast cancer survivors.
Wayne S; Neuhouser ML; Ulrich CM; Koprowski C; Wiggins C; Baumgartner KB; Bernstein L; Baumgartner RN; Gilliland F; McTiernan A; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3224-32. PubMed ID: 18957523
[TBL] [Abstract][Full Text] [Related]
13. [Concentration of selected sex hormones and SHBG in the serum of women with breast cancer treated with antiestrogens and (or) cytostatic agents].
Grodecka-Gazdecka S; Kociałkowski K
Nowotwory; 1990; 40(1):5-11. PubMed ID: 2356147
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic results with tamoxifen in oligospermia. II. Hormonal analysis and semen parameters].
Schieferstein G; Adam W; Armann J; Bantel E; Cörlin R; Egenrieder H; Fierlbeck G; Hook B; Schiek A; Schubring G
Andrologia; 1987; 19(3):333-41. PubMed ID: 3115143
[TBL] [Abstract][Full Text] [Related]
15. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
17. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
[TBL] [Abstract][Full Text] [Related]
18. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A
Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787
[TBL] [Abstract][Full Text] [Related]
19. Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.
Jiroutek MR; Chen MH; Johnston CC; Longcope C
Menopause; 1998; 5(2):90-4. PubMed ID: 9689202
[TBL] [Abstract][Full Text] [Related]
20. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
